[1]   National Research Council, “Science and Decisions: Advancing Risk Assessment,” National Academy Press, Washington DC, 2009.

[2]   D. Crawford-Brown, “The Precautionary Principle in Environmental Regulations for Drinking Water,” Environ- mental Science and Policy, Vol. 14, No. 4, 2011, pp. 379- 387. doi:10.1016/j.envsci.2011.02.002

[3]   European Commission, “Communication from the Commission on the Precautionary Principle,” COM(2000)1, Brussels, 2 February 2000.

[4]   CFR, “Protection of Environment, CFR Parts 1-49, Code for Federal Regulations,” US Environmental Protection Agency, Washington DC, 2003.

[5]   European Parliament, “Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 Concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH),” 2006.

[6]   US Senate, “Reauthorization of the Toxic Substances Control Act: Hearings before the Subcommittee on Toxic Substances, Research, and Development of the Commit- tee on Environment and Public Works,” United States Senate, One Hundred Third Congress, Second Session, May 1 2011.

[7]   D. Crawford-Brown, “Risk-Based Environmental Decisions: Methods and Culture,” Kluwer Academic Publishers, Norwell, 1999. doi:10.1007/978-1-4615-5227-7

[8]   M. Dourson, S. Felter and D. Robinson, “Evolution of Science-Based Uncertainty Factors in Noncancer Risk Assessment,” Regulatory Toxicology and Pharmacology, Vol. 24, No. 2, 1996, pp. 108-120. doi:10.1006/rtph.1996.0116

[9]   D. Crawford-Brown, “Mathematical Methods of Environmental Risk Modeling,” Kluwer Academic Publishers, Norwell, 2001. doi:10.1007/978-1-4757-3271-9

[10]   S. Moolgavkar, “The Multistage Theory of Carcinogenesis and the Age Distribution of Cancer in Man,” Journal of the National Cancer Institute, Vol. 61, No. 1, 1978, pp. 49-52.

[11]   D. Crawford-Brown, “Scientific Models of Human Health Risk Analysis in Legal and Policy Decisions,” Law and Contemporary Problems, Vol. 64, No. 4, 2001, pp. 63-81. doi:10.2307/1192291

[12]   M. Mebust, D. Crawford-Brown, W. Hofmann and H. Schoelnberger, “Testing of a Biologically-Based Exposure-Response Model from in vitro to in vivo Conditions,” Regulatory Toxicology and Pharmacology, Vol. 35, No. 1, 2002, pp. 72-79. doi:10.1006/rtph.2001.1516

[13]   D. Crawford-Brown, “The Concept of Sound Science in Risk Management Decisions,” Risk Management: An International Journal, Vol. 7, No. 3, 2005, pp. 7-20.

[14]   D. Crawford-Brown and K. Brown, “A Framework for Judging the Carcinogenicity of Risk Agents,” Risk: Health, Safety and Environment, Vol. 8, No. 2, 1997, p. 307.

[15]   I. Cote, “Challenges for Use of New Science in Risk Assessment and Regulation,” Presentation to Standing Committee on Use of Emerging Science for Environmental Decision Making, Washington DC, 2010.

[16]   M. Anderson and D. Krewski, “Toxicity Testing in the 21st Century: Bringing the Vision to Life,” Toxicological Sciences, Vol. 107, No. 2, 2009, pp. 324-330. doi:10.1093/toxsci/kfn255

[17]   T. K. Nayak and S. Kundu, “Calculating and Describing Uncertainty in Risk Assessment: The Bayesian Approach,” Human and Ecological Risk Assessment, Vol. 7, No. 2, 2001, pp. 307-328. doi:10.1080/20018091094385

[18]   J. Wilson, “Advanced Methods for Dose-Response Assessment: Bayesian Approaches, Final Report,” Resource for the Future, Washington DC, 2001. doi:10.1289/ehp.0901249

[19]   K. Crump, C. Chen, W. Chiu, T. Louis, C. Portier, R. Subramaniam and P. White, “What Role for Biologically Based Dose-Response Models in Estimating Low-Dose Risk?” Environmental Health Perspectives, Vol. 118, No. 5, 2010, pp. 585-588.

[20]   D. Krewski, V. Hogan, M. C. Turner, P. L. Zeman, I. Mc-Dowell, N. Edwards and J. Losos, “An Integrated Framework for Risk Management and Population Health,” Human and Ecological Risk Assessment, Vol. 13, No. 6, 2007, pp. 1288-1312. doi:10.1080/10807030701655798

[21]   J. Lemons, K. Shrader-Frechette and C. Cranor, “The Precautionary Principle: Scientific Uncertainty and Type I and Type II Errors,” Foundations of Science, Vol. 2, No. 2, 1997, pp. 207-236. doi:10.1023/A:1009611419680

[22]   R. Raucher, S. Rubin, D. Crawford-Brown and M. Lawson, “Benefit-Cost Analysis for Drinking Water Standards: Efficiency, Equity, and Affordability Considerations in Small Communities,” Journal of Benefit-Cost Analysis, Vol. 1, No. 1, 2011, pp. 1-22.

[23]   D. E. Savitz, “Is Statistical Significance Testing Useful in Interpreting Data?” Reproductive Toxicology, Vol. 7, No. 2, 1993, pp. 95-100. doi:10.1016/0890-6238(93)90242-Y

[24]   European Chemicals Agency, “Practical Guide 2: How to Report Weight of Evidence,” Helsinki, 2010.